AllSight
Companies · INSM · Pharmaceutical Preparations

INSMED Inc (INSM)

INSMED Inc (INSM) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

INSMED Inc (INSM) stock — financials & valuation

Key numbers for INSMED Inc (INSM): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 40/100 — a percentile rank of INSMED Inc’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.

Market cap$23.7B
P / S20.9×
EV / EBITDA-28.9×
Gross margin83.5%
Operating margin-73.9%
Net margin-76.9%
Return on equity-115.5%
ROIC-108.7%
Revenue growth185.8%
Debt / equity0.8×
Dividend yield0.0%

Is INSMED Inc overvalued? P/S looks fair vs its 5-year range; P/B looks fair vs its 5-year range.

Independent of the events above — derived from INSMED Inc’s own financial statements and shown as context, never as advice.

Aug 6, 2026
Brinsupri momentum beats expectations and lifts 2026 guidance sharply
Related companies in Pharmaceutical Preparations
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact